When stratified by treatment arm, a slight trend towards higher AUC 0–12m values was observed for cured patients compared to noncured patients in both the 200- and 300-mg fosravuconazole cohorts ( Figure 4 A ).
← all excerpts
Pharmacokinetics and Pharmacodynamics of Fosravuconazole, Itraconazole, and Hydroxyitraconazole in Sudanese Patients With Eumycetoma.
1
—
—